Japanese venture Heartseed has found that treating heart failure with iPSC-derived cardiomyocyte spheroids could achieve sustained tissue regeneration.
As of October 2021, there are 50 children nine years old and younger waiting for a heart transplant, a survey by the Japan Organ Transplant Network...